Replay LSI2021 Emerging Medtech Summit

Play Now
innovation hub

NeoStem (AMEX: NBS) is Profiled in this Database

Updated At 12 Apr, 2011

Start Free 7 Day Trial Now
Partial description of this company
1-Adult stem cell collection and storage, 2-VSEL(TM) (very small embryonic-like) stem cells for tissue regeneration, 3-Contract cell manufacturing for clients around the world, Progenitor Cell Therapy, 4-Therapeutics such as a T-cell regulatory technology to treat disorders of the immune system, 5-A wound healing technology that uses autologous bone marrow-derived stem cells, 6-An autologous bone marrow-derived cell line selected to treat damaged heart muscle following AMI

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of NeoStem (AMEX: NBS) plus 4972 other startups.

Start Free 7 Day Trial Now

Learn More About NeoStem (AMEX: NBS)

Technology/product details

CEO presentation


Our Clients